Pharmaceutics International Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pharmaceutics International Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10793
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pharmaceutics International Inc (PII) is a contract development and manufacturing organization that offers pharmaceutical product development solutions. The organization offers manufacturing of solid, semi-solid, liquid, inhalation, parenteral and aseptic filling drugs. Its services comprise early stage formulation development, CMC services and clinical support; life cycle management and commercial manufacturing services. PII offers formulation of drugs in potent compounds, bioavailability enhancement, DEA schedule, hormones and first-in-man phase I applications. The organization serves pharmaceutical industry. It serves its clients in the US and abroad. PII is headquartered in Hunt Valley, Maryland, the US.

Pharmaceutics International Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmaceutics International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Pharmaceutics International Raises USD6 Million in Venture Financing 10
Pharmaceutics International Raises USD10 Million in Venture Financing 11
Pharmaceutics International Raises USD93 Million in Venture Financing 12
Partnerships 14
Breckenridge Pharma Enters into Co-Development Agreement with Pharmaceutics International 14
Pharmaceutics International Inc – Key Competitors 15
Pharmaceutics International Inc – Key Employees 16
Pharmaceutics International Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Legal and Regulatory 18
Jun 11, 2018: Pharmaceutics International Announces Positive Inspection News from FDA and MHRA 18
Feb 08, 2018: Pii and Its Partners Received FDA Market Approval for Seven Products and Commercially Launched 6 Products in 2017 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Key Facts 2
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmaceutics International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmaceutics International Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pharmaceutics International Raises USD6 Million in Venture Financing 10
Pharmaceutics International Raises USD10 Million in Venture Financing 11
Pharmaceutics International Raises USD93 Million in Venture Financing 12
Breckenridge Pharma Enters into Co-Development Agreement with Pharmaceutics International 14
Pharmaceutics International Inc, Key Competitors 15
Pharmaceutics International Inc, Key Employees 16

List of Figures
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmaceutics International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Pharmaceutics International Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OTK GROUP, a.s.:企業の戦略・SWOT・財務分析
    SummaryOTK GROUP, a.s. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …
  • Sinotruk (Hong Kong), Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sinotruk (Hong Kong), Ltd. Merg …
  • Cap Gemini S.A.:戦略・SWOT・企業財務分析
    Cap Gemini S.A. - Strategy, SWOT and Corporate Finance Report Summary Cap Gemini S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • WCP Resources Limited (WCP):企業の財務及び戦略的SWOT分析
    Summary WCP Resources Limited (WCP) is a mineral exploration company that acquires, explores and develops gold deposits. It conducts exploration and drilling programs and estimates mineral resources for the mining industry. WCP has completed several gold project development such as Centamin’s Sukari …
  • Al Ahli Bank of Kuwait KSC:企業の戦略・SWOT・財務情報
    Al Ahli Bank of Kuwait KSC - Strategy, SWOT and Corporate Finance Report Summary Al Ahli Bank of Kuwait KSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Consumers Energy Cooperative:企業のM&A・提携動向(エネルギー分野)
    Summary Consumers Energy Cooperative (CE) is an energy utility company which provides electric and natural gas services to its customers. The company offers commercial tree service, electric construction and maintenance, energy management, generator sales and service, lighting, metering and monitori …
  • Nectar Lifesciences Ltd (NECLIFE):企業の財務・戦略的SWOT分析
    Summary Nectar Lifesciences Ltd (NecLife) is a research driven pharmaceutical company that manufactures active pharmaceutical ingredients (APIs). The company provides contract research and manufacturing services such as process development and optimization, process scale up and validation, multi kil …
  • Qualcomm Incorporated (QCOM):医療機器:M&Aディール及び事業提携情報
    Summary Qualcomm Incorporated (Qualcomm) is a technology and communication company. The company designs and manufactures digital wireless telecommunications products and services. Qualcomm offers integrated circuits and system software for wireless mobile devices. The major technologies such as code …
  • City Developments Limited:企業の戦略・SWOT・財務分析
    SummaryCity Developments Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • Aquion Energy Inc.:企業のM&A・提携動向(発電分野)
    Summary Aquion Energy Inc. (Aquion) is a power company that manufactures clean and sustainable saltwater batteries and provides energy storage solutions. The company offers products such as bulk energy storage modules, M-line battery modules, and S-line battery stacks. It uses Aqueous Hybrid Ion bat …
  • P2 Energy Solutions Inc:企業のM&A・提携動向(石油・ガス分野)
    Summary P2 Energy Solutions Inc (P2 Energy) is an oilfield services company that develops and offers oilfield software solutions. The company offers various tools for environmental, health and safety, finance and accounting, land management and geospatial data, operations, and production management. …
  • Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft:企業の戦略・SWOT・財務情報
    Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers th …
  • Garvan Institute of Medical Research(製薬・医療分野):企業M&A動向
    Summary Garvan Institute of Medical Research (Garvan Institute) is a biomedical research company. The company is a medical research institute of widespread diseases. It conducts research in the fields of cancer, diabetes and obesity, alzheimer’s and parkinson’s disease, osteoporosis, arthritis, asth …
  • ENECO Holding N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ENECO Holding N.V. Mergers and …
  • Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773):製薬・医療:M&Aディール及び事業提携情報
    Summary Chengdu Kanghong Pharmaceuticals Group Co Ltd (Chengdu Kanghong Pharmaceuticals) is a pharmaceutical company that develops, manufactures and markets Chinese medicines, chemical drugs and biological products. The company offers products for the treatment of medical conditions related to centr …
  • Archrock Partners, L.P.:企業のM&A・提携・投資分析
    Archrock Partners, L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Archrock Partners, L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Time Warner Inc.:企業のM&A・提携・投資分析
    Time Warner Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Time Warner Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Cobham plc:企業のM&A・事業提携・投資動向
    Cobham plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cobham plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Compagnie Financiere Richemont SA:企業の戦略・SWOT・財務分析
    SummaryCompagnie Financiere Richemont SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the co …
  • Reliance Money Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Reliance Money Limited Mergers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆